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Abstract. In this document we present an extensive list of argument
schemes and critical questions intended to enable agents to argue over
the viability of a given human organ. These schemes can be regarded
as a domain specific argumentation dialog game, in which the Critical
Questions of a given scheme determine the possible dialog moves. In order
to represent the wide list of Argument Schemes and Critical Questions in
a comprehensible manner we propose in this report a novel formalization
of the argument schemes interaction
1 Introduction
In this document we present an extensive list of argument schemes and their
associated critical questions to be used by agents to argue over the viability
for transplantation of a given human organ. The aim is that, by capturing a
sufficiently wide range of reasoning patterns, the schemes will enable and direct
the agents in their collaborative decision making. The context of the agents’
deliberation is given in [7].
Argument schemes can be regarded as reasoning patterns, structures of in-
ference, possibly nonmonotonic and nondeductive, that enable to identify and
evaluate common types of arguments used in a particular domain. Associated to
an argument scheme are critical questions that on the one hand identify valid
lines of reasoning that can further support the argument instantiating the scheme
and on the other hand identify the arguments that attack this argument.
In the construction of the argument scheme repository we introduced a novel
formalization that enables to easily define the argument schemes interaction. In
the following section we briefly describe the context in which this argument-based
deliberation take place. In section 3 we give the basics of the argument schemes
and we describe the notation to be used in writing the repository. In section 4 we
provide the extensive list of the argument scheme and their associated critical
questions. In section 5 we give our conclusions.
22 Arguing Over the Viability of a Human Organ for
Transplantation
Within a hospital, when a patient becomes a potential donor, the Transplant
Coordinator is responsible of determining which of the donor’s transplantable or-
gans are viable for that purpose and offer for transplantation the organs deemed
as viable. The organ offers are managed by the local Transplant Organization
which intend to allocate the offered organs to a suitable potential recipient. The
organ assignations are made via the Transplant Units responsible of the poten-
tial recipients. The Transplant Units are responsible of successfully transplanting
the offered organs. In [7] we propose a human organ selection process in which
the Transplant Coordinator (TC) offers not only the organs deemed as viable
but also the ones considered non-viable, this time however, the offered organs
will not be accompanied only by the donor’s and organ’s characteristics but also
by the arguments that support TC’s belief to whether the organ is or is not
viable. Also, prior to the allocation process, each Transplant Unit1 (TU) will be
able to contra-argue TC’s argument. In particular, a TU providing valid argu-
ments would be able to label an organ as viable even though the TC deems it
as non-viable. As a result, the organs labelled viable will be offered for alloca-
tion, via the Transplant Organization to all the TU who deemed the organ as
viable. Namely this new process enables TUs to rescue organs that would have
been discarded by the TC. In [7] besides providing a more in depth description
of both, the current human organ selection process and the proposed one, we
frame the proposed process in CARREL [8], an agent-based organization de-
signed to improve the overall transplant process. Thus, the arguments of TC
and TU, are managed by the agents Transplant Coordinator Agent (TCA) and
Transplant Unit Agent (TUA) respectively. The Mediator Agent MA evaluates
the agents’ arguments and gives the final decision, whether the organ should be
labelled viable or non-viable to each TUA. The argumentation formalization are
described in [7] and [3].
3 Argument Schemes an Critical Questions
Argument schemes capture reasoning patterns used in a particular domain.
This reasoning patterns are in fact, structures of inference. Although argument
schemes can capture monotonic deductive inference, such as modus ponens, their
interest aspect is their suitability to encode nonmonotonic and nondeductive
resoning [6]. Argument schemes enable to identify and evaluate common types
of arguments used in a particular domain. Associated to an argument scheme are
critical questions that on the one hand identify valid lines of reasoning that can
further support the argument instantiating the scheme and on the other hand
identify the arguments that attack this argument.
1 The information of the organ offer will only be sent to Transplant Units that are
responsible of a potential recipient to whom the offered organ is suitable
3Take the argument scheme Appeal to Expert Opinion that captures a sensible
reasoning, or argumentation, pattern:
AEOS Appeal to Expert Opinion Scheme:
P is an expert in domain D (1)
And P asserts A to be true (2)
And A is in domain D (3)
Therefore A is true.(4)
The critical questions associated to this scheme are:
(CQ1): Is P an expert in domain D?
(CQ2): Did P actually asserted A?
(CQ3): Is A in domain D?
(CQ4): Is P reliable?
Typically, Critical Questions (CQ) are regarded as defeaters of the argument
instantiating the scheme ([10] [5] [9] [2]). Namely, if the scheme is instantiated
by the argument A1:
john is an expert in domain medicine (1)
And john asserts mary is healthy to be true (2)
And mary is healthy is in domain medicine (3)
Therefore mary is healthy is true.(4)
The above CQs capture the possible attacks on A1. Whereas -Is john and expert
in medicine?- challenges A1, -john is unreliable- attacks A1 (in fact undercuts
A1 [4]). Note that there could be one or several schemes that conclude with the
claim -Therefore P is unreliable-2, for example the [GAH] scheme:
GAH Generic Ad Hominem Argument:
Person P is bad (1)
Therefore P is unreliable (2)
which is an adaptation of a Walton’s Generic Ad Hominem Argument scheme
[11]. Thus, the argument A2 that instantiates this scheme with P = john, at-
tacks A1 (Pollock undercuts). In general, any argument instantiating [AEO], is
attacked by argument instantiating [GAH] such that both instantiate the vari-
able P equally. Hence, all the schemes with the claim -P is unreliable- can be
regarded as associated to CQ4.
Notation 1 : We will write as [AEO](john, medicine, mary is healthy) the ar-
gument instantiating scheme [AEO] with P = john, D = medicine and A =
mary is healthy. The order of the arguments of [S-name](X1,...,Xn) is the order
2 The last line of an Argument Scheme is the scheme conclusion or claim, the other
lines are the scheme premisses. E.g. in [AEO], lines (1), (2) and (3) are the premisses,
and line (4) is the scheme claim
4of their occurrence in the scheme [S-name]. Note that words starting with small
caps are constants, otherwise they are variable.
In this report we propose to consider critical questions not only as defeaters of
a scheme, but as both, ”defeaters” and ”supporters”. In other words, to a CQ of
a scheme S1 we also associate the schemes that enable instantiation of arguments
which claims are assumptions of an argument instantiating S1. For instance we
associate to CQ1 of [AEO] any scheme that concludes with -Therefore, P is an
expert in domain D-. For instance, the scheme [EbT]:
EbT Expert because of Title:
Person P has title T (1)
And people with title T are experts in domain D (2)
Therefore, P is expert in domain D (3)
In this occasion argument A3 = [EbT](john, degree medicine, medicine),
supports premise (1) of the A1 argument.
Needless to say, that to [GAH] and [EbT] we can also associate the appro-
priate CQs. Hence, as pointed out in [9], CQ provides a dialectical nature to the
argument scheme. In particular, CQs can be viewed as the allowed moves in a
dialog game. Namely, given a proponent argument A that instantiates scheme
S, an opponent player could challenge A by instantiating one of S’s CQs, or
attack A if he is able to instantiate appropriately an attacking argument scheme
Sattacks−S associate to a CQ of S. The proponent, on the other hand, can in-
stantiate the supporting schemes of S associated to its CQ in order to either
answer to a challenge on A, or simply to further support A.
In order to represent the allowed moves of the dialog game, via argument
schemes and critical questions, in a readable fashion we propose a novel notation
which we found very useful in representing the argument-based deliberation of
our scenario.
3.1 A formalization for an Argument Scheme based Dialog Game
In constructing a repository of argument schemes an their associated critical
questions for the agents to argue over the viability of a human organ, we found
in the literature little help on how to represent a considerable amount of schemes
that were associated via CQ. Also, when developing the new notation we felt a
requirement from our working context to enrich the notation in order to repre-
sent aspects such as the agents’ roles or control flows, that we believe are useful
for other contexts as well.
Definition 1. An instantiation link of a critical question CQk associated to a
scheme S is a duple ICQk = (Attack, Support) where Attack is a possibly empty
set of schemes a1, a2..., an and control flows f1, ..., fm such that:
– For i = 1...n, there exist x1, x2, ..., xr and y1, ..., yt, constants, such that the
argument ai(x1, x2, ..., xr) attacks the argument S(y1, ..., yt).
5– fi is of the form (op(F)? A B), where op is a boolean operator. If op validates
formula F, fi is substituted by A, otherwise, it is substituted by B. Where A
and B are, in turn, sets, possibly empty, of schemes and control flows. The
schemes in both A B have the same property of the ai schemes. If op(F)
evaluates positively F and the set A is empty, then the argument instantiating
S is defeated.
Similarly, Support = {s1, s2, ..., su, g1, ..., gv}, where si are argument schemes
and gi control flows, such that:
– For i = 1...u, there exist x1, x2, ..., xr and y1, ..., yt, constants, such that the
argument si(x1, x2, ..., xr) claim is one of the premisses of S(y1, ..., yt).
– gi, i = 1,...,v are control flows. Where the schemes in both Aand B have the
same property of the si schemes. If op(F) evaluates positively F and the set
A is empty, the challenge raised by CQk is answered. Namely, the argument
instantiating S is not defeated by the challenge raised by CQk.
The Instantiation Link of CQ1 of [AEO]: -Is P an expert in domain D? -, at
this stage could be:
ICQ1 = ({∅}, {[EbT ]})3.
The instantiation link of the CQ3 of [AEO]: -Is A in domain D? -, could be:
ICQ3 = ({(KB(A ∈ D)? ∅ ∅)), [AEO]}, {(KB(A /∈ D)? ∅ ∅)), [AEO]})
Where KB(A ∈ D)? is a query to a Knowledge Base.
The instantiation link of CQ4 of [AEO]: -Is P reliable? -, could be:
ICQ4 = ({[GAH]}, {∅})
Therefore, in this context, a proponent can make his first move
A1 = [AEO](john,medicine,mary is healthy). The opponent may then chal-
lenge A1 via CQ1: Is john an expert in domain medicine? to which the propo-
nent may answer A2 = [EbT](john, degree medicine,medicine). The opponent
may then use the CQs associated to [EbT] in order defeat or challenge A2, or
use a CQ associated to [AEO] other than CQ1.
Note that the supporting set of ICQ4 is empty, therefore, given the challenge:
-Is john reliable? - the proponent has no possible moves. Within the dialog game,
if ICQk = ({∅}, Support) and Support is a non empty set, the burden of proof is
on the proponent, i.e if the opponent raises a challenge via CQk the proponent
must answer to the challenge. Conversely, if ICQk = (Attack, {∅}) and Attack
is non empty, the burden of proof is on the opponent, thus, in our example,
the challenge -Is john reliable? - is not applicable, the only possible move of the
opponent via CQ4 is B1 = [GAH](john).
3 Note that ICQ1 = ({[AEO]}, {[EbT ], [AEO]}) is also a possible instantiation link.
6If both sets Attack and Support are empty, the argument acceptability is
unresolved. In our context, the Mediator Agent, decides whether the argument
is accepted or defeated.
Definition 2. A Critical Question can be regarded as: -if the formula F is true
then the scheme is defeated-. If the Conjunctive Normal Form of the formula F
associated to the critical question CQk is F = C1 ∧ C2 ∧ ... ∧ CN , the Arity of
the CQk is N . (Or, CQk is a N-step critical question).
To attack a scheme through an N-step CQ, the opponent has to show C1, C2, ...
and CN to be true. To show that Cj is true, the proponent can instantiate an
argument scheme SCjk which claim is Cj
4 or challenge the proponent with -Is
it the case that ¬Cj? - to which the proponent is not be able to answer. We
assume that in order to show Ck (k > 1) a player must first show Ck−1 (Ck−1
is a precondition to question Ck).
With a N -step CQ comes an Instantiation link of depth N , in which the
the first layer of I refers to C1 and the k layer refers to Ck. Thus we write the
instantiation link I of depth N as:
I1 = ({a11, a12, ..., a1n, f11, ..., f1u}, {s11, s12, ..., s1m, g11, ..., g1v})
I2 = ({a21, a22, ..., a2n, f21, ..., f2u}, {s21, s22, ..., s2m, g21, ..., g2v})
...........
IN = ({aN1, aN2, ..., aNn, , fN1, ..., fNu}, {sN1, sN2, ..., sNm, gN1, ..., gNv})
Therefore, to answer effectively to a challenge raised by this critical question,
the proponent must instantiate effectively one of the sjkj
5 argument schemes.
On the other hand, in order to defeat the argument instantiating the scheme via
the N-step CQ, the opponent must instantiate effectively a sequence of argument
schemes a1k1 , a2k2 , ..., aNkN
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Let us Take the argument scheme for the viability of a human organ:
VS Viability scheme:
No absolute contraindications were found in donor D (1)
And no absolute contraindications were found in Organ O (2)
And there can be a matching recipient for O (3)
And no logistical problems are expected (4)
And no wrong course of action A is intended (5)
Therefore, organ O is viable. (6)
To this scheme we associate the CQ:
(CQ1) Does D have Absolute Contraindication C1 for donating O?
4 Also, Cj could be validated by an operator, for instance, (KB(Cj)? ∅ B).
5 If the burden of proof is on the opponent, the proponent does not have to answer.
6 If, for instance, on level j, the burden of proof is on the proponent, and the proponent
is unable to show that ¬Cj , then ajkj = ∅.
7(CQ1) can be regarded as: donor has(D,C1)∧contraindication(C1)? Note that
claiming that donor has(D,C1) is not a reason to defeat an argument instan-
tiating [VS], neither is claiming contraindication(C1). Thus, the opponent has
to first show that donor has(D,C1) and then show that contraindication(C1).
Conversely, the proponent has to show that either ¬donor has(D,C1) or that
¬contraindication(C1).
Before presenting the argument schemes and critical questions repository, we
must introduce a new notion into the instantiation link definition:
Definition 3. Given an instantiation link ICQk = ({a1, .., an, f1, ..., fu},
{s1, ..., sm, g1, ..., gv}) as defined in definition 1. Then both, ai and sj have the
form [S-ID]R where S-ID is the identifier of the scheme, and R is a set of roles.
This denotes that, only agents that play roles that are in R can instantiate [S-ID].
4 Argument scheme repository to argue over the viability
of a human organ
In our context, we can identify three roles: the agent representing the Transplant
Coordinator, TCA, the agent representing the Transplant Unit, TUA, and the
agent mediating de deliberation, MA. Normally, TCA will start putting forward
an argument for viability (resp. non-viability) and TUA will attempt to defeat
TCA’s claim. It is worth mentioning, that although we are presenting this sce-
nario as opponent vs. proponent, it fact, it should be regarded as a collaborative
decision making.
Provided that MA can make use of any instantiation of the schemes, we
define the role sets: d = {TCA,MA} and r = {TUA,MA}, such that [S-ID]d
(resp. [S-ID]r) are schemes that can only be instantiated from the donor’s side
(resp. Recipient). If all the agents can instantiate the scheme we will simply
write [S-ID].
In our context the control flows we use are:
– (KB(F )? A B) where KB is MA’s knowledge base. (ACKB and CBRe, see
[7])
– (Rep(F )? A B) where Rep(F ) is the reputation of the agent instantiat-
ing the CQ, and F is a dimension of the reputation, i.e. F ∈ {follow up,
transplant operation, logistics...}. In general we will write (Rep? A B).
– (commit(F )? A B), if the agent commits to F then A otherwise, B. In
general, we use (commit(F )? ∅ ∅), thus, for simplicity we write commit(F )
A common sequence of control flow, when the CQ has the form -Is it the case
that F? - is:
(KB(F )? ∅ (Rep? commit(F ) ∅))
Supposing this is an element of the Attack set of an instantiation link, in our
context, this means that if the MA’s knowledge base validates F the argument
instantiating the scheme is defeated. Otherwise, if the agent instantiating this
8control flow has good reputation with respect to F it can commit to F (or
promise that F holds, or will hold). But if the agent does not commit to F or it
does not have good reputation (w.r.t F ) and the MA’s knowledge base does not
validates F , the argument cannot be defeated through this Attack element.
In what follows we enumerate the argument schemes and critical questions
of our repository following the proposed formalization.
VS Viability scheme:
No absolute contraindications were found in donor D (1)
And no absolute contraindications were found in Organ O (2)
And there can be a matching recipient for O (3)
And no logistical problems are expected (4)
And No wrong course of action A is intended (5)
Therefore, organ O is viable. (6)
CQ1: Does D have Absolute Contraindication C1 for donating O?
I1: ({[PAS]d, [PACRS]d}, {(KB(common(C1)7)? {[PAS]d, [PACRS]d} ∅)})
I2: ({[DGFS], [DDTS], [DRFS], [DRFOS]}, {∅})
CQ2: Does O have Absolute Contraindication C2 for being implanted?
I1: ({[OPAS]d}, {[OPAS]d})
I2: ({[OGFS], [ODTS]}, {(KB(common(C2))? [OPAS] ∅)})
CQ3: Is there a matching recipient R for O of D?
I: ({[NMS]r}, {commit(match)r})
CQ4: Are there expected Logistical Contraindications L ?
I: ({[LCS]}, {(Repr? ∅ commit(¬L))})
CQ5: Is the wrong course of action A1 intended on D?
I: ({[DCACS]}, {(Repr? ∅ commit(¬intended(A1, D)))})
CQ6: Is the wrong course of action A2 intended on R?
I: ({[RCACS1]r, [RCACS2]r}, {(Repr? ∅ commit(¬intended(A2, R)))})
NVS1 Non-Viability scheme (Donor Contra):
Donor D of organ O has C (1)
And C is a an Absolute Contraindications for donating O (2)
Therefore, organ O is non-viable. (3)
CQ1: Does D have C?
I: ({∅}, {[PAS]r, [PACRS]d})
CQ2: Is C an Absolute Contraindication for donating O?
I: ({[RPDS], [DCES]}, {[DGFS], [DDTS], [DRFS], [DRFOS]})
7 The TCA has to show that the donor D does not have property C1 only in the case
where C1 is a common contrainidcation.
9NVS2 Non-Viability scheme (Organ Contra):
Organ O has C (1)
And organ O with C cannot be transplanted (2)
Therefore, organ O is non-viable. (3)
CQ1: Does O have C?
I: ({∅}, {[OPAS]r})
CQ2: Can an organ with C be transplanted?
I: ({[RPOS], [OCES]}, {[OGFS], [ODTS]})
NVS3 Non-Viability scheme (Logistical Contra):
Organ O is expected to arrive to recipient R in time T1.(1)
And Organ O’s cold ischemia time is T2 (2)
T1 ≥ T2 (3)
Therefore organ O is non-viable. (4)
CQ1: Is the expected time T1?
I: ({∅}, {[LCS]r})
CQ2: Is O’s cold ischemia time T2?
F = coldIschemia(O) ≤ T2
I: ({(KB(F )? (Rep? commit[¬F ] ∅) ∅)},
{(KB(¬F )? (Rep? commit[F ] ∅) ∅)})
NVS4 Non-Viability scheme (Procedural Contra on Donor):
Donor D has organ O (1)
And carrying out course of action A on donor during D’s procurement phase
has as a consequence C on D. (2)
And C is an absolute contraindication for donating O (3)
And A is carried out on D (4)
Therefore, organ O is non-viable. (5)
CQ1: Does A on D has as a consequence C?
F = dcourse act(A,D)→ result d p(D,C)e
I: ({(KB(F )? (Rep? commit[¬F ] ∅) ∅)},
{(KB(¬F )? (Rep? commit[F ] ∅) ∅)})
CQ2: Is C on D an absolute contraindication?
I: ({∅}, {[DGFS], [DDTS], [DRFS], [DRFOS]})
CQ3: Was A carried out on D?
I: ({(Repd? ∅ commit[¬course act(A,D)])}, {∅})
NVS5 Non-Viability scheme (Procedural Contra on Organ):
Donor D has organ O (1)
And carrying out course of action A on donor during D’s procurement phase
has as a consequence C on O. (2)
And C is an absolute contraindication for donating O (3)
And A is carried out on D (4)
Therefore, organ O is non-viable. (5)
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CQ1: Does A on D has as a consequence C on O of D?
F = dcourse act(A,D) ∧ d(D,O)→ result o p(O,C)e
I: ({(KB(F )? (Rep? commit[¬F ] ∅) ∅)},
{(KB(¬F )? (Rep? commit[F ] ∅) ∅)})
CQ2: Is C an absolute contraindication?
I: ({∅}, {[OGFS], [ODTS]})
CQ3: Was A carried out on D?
I: ({(Repd? ∅ commit[¬course act(A,D)])}, {∅})
NVS6 Non-Viability scheme (Procedural Contra 2):
Transplanting organ O from donor D to recipient R (1)
And performing A to R in the post-transplant has as a consequence C on R
(2)
And C is harmful. (3)
And course of action A is intended on R (4)
Therefore, organ O is non-viable. (5)
CQ1: Does course of action A on R has as a consequence C on R?
F = dcourse act(A,R)→ result r p(R,C)e
I: ({(KB(F )? (Rep? commit[¬F ] ∅) ∅)},
{(KB(¬F )? (Rep? commit[F ] ∅) ∅)})
CQ2: Is C harmful?
I: ({[DCES6], [OCES6], [DCES4], [OCES4]}, {∅})
CQ3: Is A intended to be carried out on R?
I: ({(Repr? ∅ commit[¬course act(A,R)])}, {∅})
NVS7 Non-Viability scheme Match:
There is no matching recipient for organ O (1)
Therefore, organ O is non-viable. (2)
CQ1: Is there a matching recipient R for organ O?
I: ({commitr(match(O,R))}, {commitr(¬match(O,R))})
DGFS Donor Graft Failure Contraindication Scheme:
Organ O of donor D (1)
And organs O of donors with C usually have Graft Failure when trans-
planted. (2)
Therefore, C is an Absolute Contraindication. (3)
CQ1: Is it really the case of Graft Failure when donors have C?
F = dd(D,O) ∧ d p(D,C)→ result r gf(O,R)e
I: ({(KB(F )? (Rep? commit[¬F ] ∅) ∅)},
{(KB(¬F )? (Rep? commit[F ] ∅) ∅)})
CQ2: Does condition C2 on recipient R prevent Graft Failure?
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I: ({[RPGFDS]}, {∅})
OGFS Organ Graft Failure Contraindication Scheme:
Organ O of donor D (1)
And organ O with C usually have Graft Failure when transplanted. (2)
Therefore, C is an Absolute Contraindication. (3)
CQ1: Is it really the case of Graft Failure when the organ O has C?
CQ2: Does condition C2 on recipient R prevent Graft Failure?
DDTS Donor Disease Transfer Contraindication Scheme:
Donor D of organ O has C1 (1)
And when transplanting O from donor with C1 to recipient R, R may end
up having C2 (2)
And C2 is harmful. (3)
Therefore, C1 is an Absolute Contraindication. (4)
CQ1: Is it really the case that R will have C2?
F = dd p(D,C1)→ result r p(R,C2)e
I: ({(KB(F )? (Rep? commit[¬F ] ∅) ∅)},
{(KB(¬F )? (Rep? commit[F ] ∅) ∅)})
CQ2: Is C2 harmful considering R’s condition?
I: ({[RPCDS], [RPCS]}, {∅})
CQ3: Is there a course of action A that can prevent R from having C2?
I: ({[DCAPS]}, {∅})
ODTS Organ Disease Transfer Contraindication Scheme:
Organ O of donor D with C1 (1)
And when transplanting O with C1 to recipient R. (2)
And R will have C2 (3)
And C2 is harmful (4)
Therefore C1 is an Absolute Contraindication. (5)
CQ1: Is it really the case that R will have C2?
CQ2: Is C2 harmful considering R’s condition?
The instantiation links are equivalent to the previous scheme
DRFCS Donor Risk Factor Contraindication Scheme:
Donor D of Organ O has RF (1)
And donors having RF are very likely to have C (2)
And C is an Absolute Contraindication for transplanting O(3)
Therefore RF is an Absolute Contraindication. (4)
CQ1: Does D have RF?
I: ({∅}, {[PAS]d, [PACRS]d})
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CQ2: Do tests show that D does not have C?
I: ({∅}, {[PAS]d})
CQ3: Is C on D an Absolute Contraindication for donating O?
I: ({∅}, {[DGFS], [DDTS]})
DRFCOS Donor Risk Factor Contraindication on Organ Scheme:
Donor D of Organ O has RF (1)
And donors having RF are very likely to have C on O (2)
And C is an Absolute Contraindication for transplanting O (3)
Therefore RF is an Absolute Contraindication. (4)
CQ1: Does D have RF?
I: ({∅}, {[PAS]d, [PACRS]d})
CQ2: Do tests show that O does not have C?
I: ({∅}, {[OPAS]d})
CQ3: Is C on O an Absolute Contraindication?
I: ({∅}, {[OGFS], [ODTS]})
DCAPS Donor Course of Action Prevention Scheme:
Following course of action A1 on donor D and A2 on recipient R prevent C1
on D result in C2 on R (1)
And A1 and A2 are applied (2)
Therefore R will not result in having C2 as a consequence of D having C1.(3)
CQ1: Does A = (A1, A2) prevent R from having C2?
F = course act(A1, D)∧course act(A2, R)→ ¬dd p(D,C1)→ result r p(R,C2)e
I: ({(KB(¬F )? (Rep? ∅ commit[¬F ]) ∅)},
{(KB(F )? ∅ (Rep? commit[F ] ∅))})
CQ2: Can A1 be performed on D?
I: ({[DCACS]d}, {∅})
CQ3: Can A2 be performed on R?
I: ({[RCACS1]r, [RCACS2]r}, {∅})
OCAPS Organ Course of Action Prevention Scheme:
The CQs and instantiation links are equivalent to the previous scheme
DCAPGFS Donor Course of Action Prevention GF Scheme:
Following course of action A1 on donor D and A2 on recipient R prevent C
on D result in R having a Graft Failure (2)
And A1 and A2 are applied (3)
Therefore R will not result in having a Graft Failure as a consequence of
donor D of organ O having C.(3)
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CQ1: Does A = (A1, A2) prevent R from having a Graft Failure?
F = course act(A1, D)∧course act(A2, R)→ ¬dd p(D,C)→ result r gf(R,O)e
I: ({(KB(¬F )? (Rep? ∅ commit[¬F ]) ∅)},
{(KB(F )? ∅ (Rep? commit[F ] ∅))})
CQ2: Can A1 be performed on D?
I: ({[DCACS]d}, {∅})
CQ3: Can A2 be performed on R?
I: ({[RCACS1]r, [RCACS2]r}, {∅})
OCAPGFS Organ Course of Action Prevention GF Scheme:
The CQs and instantiation links are equivalent to the previous scheme
RPCS Recipient condition Prevention Contraindication Scheme:
Donor D of Organ O (1)
And Recipient R having C1 prevents property
resulting in having C2 being a contraindication(2)
And Recipient R has C1 (3)
Therefore, R resulting in having C2 is not a contraindication.(4)
CQ1: Does R have C2?
I: ({∅}, {[PAS]r, [PACRS]r})
CQ2: Does C1 on R prevent having C2 being a contraindication.
F = r p(R,C1) ∧ d(D,O)→ ¬dresult r p(R,C2)→ contra(D,O)e
I: ({(KB(F )? (Rep? commit[¬F ] ∅) ∅)},
{(KB(¬F )? (Rep? commit[F ] ∅) ∅)})
RPGFDS Recipient condition Prevention GF on Donor Scheme:
Donor D of Organ O has C1 (1)
And Recipient R has C2 (2)
And C2 on R prevents C1 on D of resulting in a Graft Failure on R (3)
Therefore, R will not result in having a Graft Failure because of C1 on D(4)
CQ1: Does R have C2?
I: ({∅}, {[PAS]r, [PACRS]r})
CQ2: Does C2 on R prevent having a Graft Failure.
F = r p(R,C2) ∧ d(D,O)→ ¬dd p(D,C1)→ result r gf(R,O)e
I: ({(KB(F )? (Rep? commit[¬F ] ∅) ∅)},
{(KB(¬F )? (Rep? commit[F ] ∅) ∅)})
RPGFOS Recipient condition Prevention GF on Organ Scheme:
The CQs and instantiation links are equivalent to the previous scheme
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RPDS Recipient Precarious for Donor Property Scheme:
Donor D of Organ O has C (1)
Recipient R is in a precarious condition (2)
And organ O of donor D with C can be transplanted on R if R is in a
precarious condition. (3)
Therefore, C is not an Absolute Contraindication for donating O on R. (4)
CQ1: Is C an Absolute Contraindication even if R’s condition precarious?
F = precarious(R)→ ¬dd p(D,C)→ contra(D,O)e
I: ({(KB(F )? (Rep? commit[¬F ] ∅) ∅)},
{(KB(¬F )? (Rep? commit[F ] ∅) ∅)})
RPOS Recipient Precarious for Organ Property Scheme:
The CQs and instantiation links are equivalent to the previous scheme
DCES Donor Classification Exception Scheme:
Donor D of Organ O has C1 (1)
And D has C2, a subclass of C1 (C2 more specific than C1) (2)
And C2 is not an absolute contraindication. (3)
Therefore, C is not an Absolute Contraindication for donating O in D.(4)
CQ1: Is C2 a subclass of C1?
I: ({(KB(subclass(C2, C1)?∅∅)}, {(KB(subclass(C2, C1)?∅∅)})
CQ2: Does D have C2?
I: ({∅}, {[PAS]d, [PACRS]d})
CQ3: Does D have C3 subclass of C1, and C3 is not C2?
F = subclass(C3, C1) ∧ (set(C2) ∩ set(C3) = ∅) 8
I: ({(KB(F )? ∅ ∅)}, {(KB(F )? ∅ ∅)})
OCES Organ Classification Exception Scheme:
The CQs and instantiation links are equivalent to the previous scheme
RPCDS Recipient Preferred Condition on Donor Scheme:
Donor D of Organ O has C1 (1)
And transplanting O to R may result in R having C2
R has C3. (2)
And transplanting O to R may result in R not having C3 (3)
And having C2 is preferable to having C3 (4)
Therefore, C1 is not an Absolute Contraindication for transplanting O to R.
(5)
8 This could be addressed as a 2-Step Critical Question
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CQ1: Does R have C3?
I: ({∅}, {[PAS]r, [PACRS]})
CQ2: Is C3 preferable to C2?
F = pref prop(C1, C2)
I: ({(KB(¬F )? (Rep? commit[F ] ∅) ∅)},
{(KB(F )? (Rep? commit[¬F ] ∅) ∅)})
RPCOS Recipient Preferred Condition on Organ Scheme:
The CQs and instantiation links are equivalent to the previous scheme
NMS Non Matching Scheme:
Recipient R has value V 1 on property P1. (1)
And Organ O has value V 2 on property P2 (2)
And If R has V 1 in P1 and O has V 2 in P2 then, O does not match R (3)
Therefore, R does not Match O (4)
CQ1: Does O has value V 2 in P2
I: ({∅}, {[PAS]d, [PACRS]d)})
CQ2: Does R has value V 1 in P1
I: ({∅}, {[PAS]r, [PACRS]r)})
CQ3: Is it a reason for non matching?
F = organHas(O,P2, V 2)∧recipientHas(R,P1, V 1)→ ¬Match(O,R)
I: ({(KB(F )? (Rep? commit[¬F ] ∅) ∅)},
{(KB(¬F )? (Rep? commit[F ] ∅) ∅)})
DCACS Donor Course of Action Contraindication Scheme:
Action A is intended on donor D of organ O. (1)
And carrying out A on D may have as an effect C on D (2)
And C is a contraindication for donating O (3)
Therefore, A is a wrong course of action on D for donating O (4)
CQ1: Is A intended on D
I: ({(Repd? commit[¬course act(A,D)]) ∅}, {∅})
CQ2: Does A entails C on D?
F = dcourse act(A,D)→ d p(D,C)e
I: ({(KB(F )? (Rep? commit[¬F ] ∅) ∅)},
{(KB(¬F )? (Rep? commit[F ] ∅) ∅)})
CQ3: Is C a Absolute Contraindication.
I: ({∅}, {[DGFS], [DDTS], [DRFS], [DRFOS]})
RCACS1 Recipient Course of Action Contraindication Scheme:
Action A is intended on R to be transplanted with O. (1)
And carrying out A on R may have as an effect C on R (2)
C is harmful. (3)
Therefore, A is a wrong course of action on D for donating O (4)
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CQ1: Is A intended on R
I: ({(Repr? commit[¬course act(A,R)]) ∅}, {∅})
CQ2: Does A entails C on R?
F = dcourse act(A,R)→ result r p(R,C)e
I: ({(KB(F )? (Rep? commit[¬F ] ∅) ∅)},
{(KB(¬F )? (Rep? commit[F ] ∅) ∅)})
CQ3: Is C harmful considering R’s condition.
I: ({[DECS6]}, {∅})
RCACS2 Recipient Course of Action Contraindication Scheme:
Action A is intended on R to be transplanted with O. (1)
And R has C1 (2)
And carrying out A on R having C1 may have as an effect C2 on R (3)
And C2 is harmful. (4)
Therefore, A is a wrong course of action on D for donating O (5)
CQ1: Is A intended on R
I: ({(Repr? ∅ commit[¬course act(A,R)])}, {∅})
CQ2: Does A with C1 entails C2 on R?
F = dcourse act(A,R) ∧ r p(R,C1)→ result r p(R,C2)e
I: ({(KB(F )? (Rep? commit[¬F ] ∅) ∅)},
{(KB(¬F )? (Rep? commit[F ] ∅) ∅)})
CQ3: Is C2 harmful considering R’s condition.
I: ({[DECS6]}, {∅})
LCS Logistical Contraindication Scheme:
Problem P may occur during the transplant process of O. (1)
And if P occurs, O’s cold ischemia is expected to be T1 greater than allowed
time T2. (2)
Therefore, P is a Logistical Contraindication. (3)
CQ1: Will P occur?
I: ({(Repr? commit[¬logis expect(P )] ∅)}, {( ∅})
CQ2: Is there course of action A that can prevent P from happening in O’s
transplant process?
F = possible logis act(A) ∧ (logis course act(A)→ ¬logis expect(P ))
I: ({(KBr(¬F )? (Rep? commit[F ] ∅) ∅)},
{(KBr(F )? (Rep? commit[¬F ] ∅) ∅)})
PAS Donor Property Affirmation Scheme:
Patient P gave result U on test S (1)
And having result U on test S entails that patient P has C. (2)
Therefore, P has C. (4)
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CQ1: Is U a conclusive result for test S?
F = result(S,U)→ ¬dtest(S)→ has(P,C)e
I: ({[PNS2], (KB(¬F )? (Rep? commit[F ] ∅) ∅)},
{(KB(F )? (Rep? commit[¬F ] ∅) ∅)})
CQ2: Is S a reliable test to test C on P?
F = dpositiveTest(S,C)→ has(P,C)e
I: ({[PNS1], (KB(F )? (Rep? commit[¬F ] ∅) ∅)},
{(KB(¬F )? (Rep? commit[F ] ∅) ∅)})
OPAS Organ Property Affirmation Scheme:
The CQs and instantiation links are equivalent to the previous scheme
PACRS Donor Property Affirmation based on Clinical Records Scheme:
Clinical records state that patient P has property C (1)
Therefore, P has C. (2)
CQ1: Does test T shows that P does not have C?
F = common(T ) ∧ dataOf(T,C)
I: ({[PAS])}, {(KB(F )? [PAS] ∅)})
PNS1 Property Negation Scheme:
Patient P gave result U on test S (1)
And result U on test S is not conclusive result to determine C on P (2)
Therefore P may not have C. (3)
CQ1: Is there another test S2 that concludes that P has C?
I: ({[PAS]}, {∅}, )
CQ2: Is test S unreliable?
F = dpositiveTest(S,C)→ has(P,C)e
I: ({(KB(¬F )? (Rep? commit[F ] ∅) ∅)},
{(KB(F )? (Rep? commit[¬F ] ∅) ∅)})
OPNS1 Organ Property Negation Scheme:
The CQs and instantiation links are equivalent to the previous scheme
PNS2 Property Negation Scheme:
Patient P gave result U on test S (1)
Test S is not a reliable test to determine C on P (2)
Therefore D may not have C. (3)
CQ1: Is S unreliable for determining C on D?
F = dpositiveTest(S,C)→ has(P,C)e
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I: ({(KB(¬F )? (Rep? commit[F ] ∅) ∅)},
{(KB(F )? (Rep? commit[¬F ] ∅) ∅)})
CQ2: Is there another test S2 that concludes that D has C?
I: ({[PAS]d}, {∅})
OPNS2 Organ Property Negation Scheme:
The CQs and instantiation links are equivalent to the previous scheme
We know give two short dialog examples in which the agents make use of the


















hcv: Hepatitis C VirusAttack: Support:
Fig. 1. A TCA offers the organ as non-viable, the TUA contra-argues claiming that
kidney is viable because its patient also has hepatitis C, and it does not believe that a
kidney of an elderly person should be discarded, which is supported by the MA agent.
5 Conclusion
In this report we present a novel formalization of argument schemes and critical
questions in order to enable agents to argue over the viability of a human organ.
The most similar work we have found in the literature is the PARMA protocol [1],
which is a multi-agent dialogue game protocol that enables argument over pro-
posals for action. The argument schemes and the attack relations to an argument
involved in this protocol have a rather high level reasoning representation (e.g.
attack relations are formalized as sentences like Disagree with the description of




*  sve = streptococcus viridans endocarditis















Fig. 2. In this dialog the TCA argues that the organ is viable if the recipient is admin-
istrated with penicillin. The TUA contra-argues claiming that it cannot administrate
penicillin to its patient given that she is allergic, thus it may cause her to have ana-
phylaxis. The MA then propose to administer teicoplanin.
proposal is somewhat less general, but we believe it to be readily implementable.
Moreover, we believe our formalization to be expressive enough as to capture a
wide range of deliberative scenarios, as long as there is a reduced number of
concrete reasoning patterns that can capture the overall deliberative process.
Within argumentation theory, argument schemes are a standard way with
which to encode rules. We regarded argument schemes as being coherent with
our previous work and formalization [7] and [3]. There are two other aspects that
motivated our use of argument schemes and critical questions:
– ”By explicitly handling argumentation schemes it becomes possible for agents
to at once broaden the scope of the relevant information, and at the same
time, narrow down selection on the basis of the argument schemes detected”
[5]. In other words, agents are directed by the CQ in order to further support
their arguments or to attack an argument that they disagree with. Note that
not all disagreements are logically derivable (in a straight forward way), for
example [DCAPS]CQ3-Can A2 be performed on R? -. Also not all the pos-
sible logical disagreements are applicable in certain contexts (e.g. in scheme
[VS] there is no point in putting forward the challenge -Is O D’s organ? -
despite being a valid challenge from a logical point of view)
– Argument Schemes and Critical Questions provide us with a useful concep-
tual framework in which to elicit the required argumentation knowledge from
physicians with experience in deciding the viability of human organs. The
pseudo natural language used to represent this defeasible rules (argument
schemes), and their defeaters (critical questions) enable to readily compre-
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hend the content of these rules and propose new rules or changes in the
existing ones.
In both, [7] and [3], we address the agents argument based deliberation as a
three step process, in which a TCA provides its arguments, then TUA contra-
argue and finally, MA evaluates the arguments, being able also to add its own
arguments. This process does not conflict with the argument scheme formaliza-
tion at hand, since, as we pointed out above, critical questions not only identify
the defeaters of an argument, but also the lines of reasoning that enable to fur-
ther support a given argument. Also in [3] we express our intention to address
the agents’ deliberation from a dialogical perspective.
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